Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/futuretox-v

Presentations at FutureTox V

Organ-specific Toxicology 
May 10-11, 2022 - Chapel Hill, North Carolina, USA

Visit meeting website

ICCVAM Committee Participation

  • Suzanne Fitzpatrick, FDA Center for Food Safety and Applied Nutrition (ICCVAM principal agency representative, FDA) and Donna Mendrick, FDA National Center for Toxicological Research (ICCVAM member, FDA) were members of the conference organizing committee.
  • Donna Mendrick, FDA, was a lead discussant for the following plenary sessions:
    • New Models for Evaluating Effects of Drugs and Chemicals on the Liver
    • New Technologies for Organ Injury for Prediction and Assessment
  • Suzanne Fitzpatrick, FDA, Donna Mendrick, FDA, and Acting NICEATM Director Nicole Kleinstreuer (ICCVAM member, NIEHS) led breakout group discussions at the end of the meeting.

NICEATM Poster Presentations

Fit for Purpose Evaluations of In Vitro Assays for IVIVE
Authors: X Chang, S Bell, J Abedini, D Allen, N Kleinstreuer
View Chang et al poster

Integrating Parameter Uncertainty in PBPK Modeling
Authors: 
D Hines, J Abedini, D Allen, N Kleinstreuer, K Mansouri
View Hines et al poster

Developing In Vitro Assay Annotations to Provide Context and Facilitate Interpretation Toward Toxicological Endpoints
Authors: 
AL Karmaus, P Ceger, J Rooney, S Bell, D Allen, N Kleinstreuer
View Karmaus et al poster